医学
奇纳
乳腺癌
心理信息
心理干预
随机对照试验
系统回顾
认知
内科学
物理疗法
肿瘤科
荟萃分析
癌症
梅德林
精神科
法学
政治学
作者
Ruairí Floyd,Adam H. Dyer,Seán Kennelly
标识
DOI:10.1016/j.jgo.2020.05.012
摘要
Purpose Cognitive impairment is a well-reported side-effect of chemotherapy in persons with breast cancer. Whilst non-pharmacological interventions have proven efficacious in the management of cognitive impairment in high-risk groups, their efficacy in cognitive impairment post-chemotherapy in patients with breast cancer remains unclear. Methods Medline, CINAHL, PsycINFO, Web of Science and Cochrane were searched for randomized controlled trials of non-pharmacological interventions for cognitive impairment post-chemotherapy in women with breast cancer. Results Of 429 results, 83 full-texts were reviewed with ten meeting inclusion criteria. Interventions included cognitive training, exercise and complementary therapies. The non-pharmacological interventions assessed displayed variable benefits in subjective and/or objective cognitive assessments, with no strong evidence for beneficial effects across included studies. No studies assessed the efficacy of multi-domain interventions. Conclusions There is mixed evidence supporting non-pharmacological interventions for cognitive impairment post-chemotherapy in women with breast cancer. Moving forward, multidomain trials combining non-pharmacological interventions are imperative in this high risk cohort.
科研通智能强力驱动
Strongly Powered by AbleSci AI